“[Budget Impact Analysis of Idarucizumab for the Management of Patients Treated With Dabigatran in Emergency Urgent Situations in Italy]”. Farmeconomia. Health Economics and Therapeutic Pathways 17, no. 2 (June 28, 2016): 47–58. Accessed February 15, 2026. https://journals.seedstm.com/index.php/FE/article/view/1243.